SomaLogic, Inc.
SLGC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $97,666 | $81,626 | $55,889 | $32,187 |
| % Growth | 19.7% | 46.1% | 73.6% | – |
| Cost of Goods Sold | $43,364 | $33,463 | $22,614 | $49,720 |
| Gross Profit | $54,302 | $48,163 | $33,275 | -$17,533 |
| % Margin | 55.6% | 59% | 59.5% | -54.5% |
| R&D Expenses | $73,444 | $43,496 | $30,749 | $32,502 |
| G&A Expenses | $153,119 | $77,271 | $36,682 | $33,324 |
| SG&A Expenses | $156,619 | $77,971 | $36,882 | $33,424 |
| Sales & Mktg Exp. | $3,500 | $700 | $200 | $100 |
| Other Operating Expenses | $1,945 | $681 | $0 | $0 |
| Operating Expenses | $230,063 | $121,467 | $67,631 | $33,989 |
| Operating Income | -$175,761 | -$73,304 | -$34,356 | -$50,957 |
| % Margin | -180% | -89.8% | -61.5% | -158.3% |
| Other Income/Exp. Net | $65,887 | -$14,205 | -$18,659 | -$6,045 |
| Pre-Tax Income | -$109,874 | -$87,547 | -$53,015 | -$57,002 |
| Tax Expense | -$717 | -$1,245 | $18,338 | $0 |
| Net Income | -$109,157 | -$86,302 | -$71,353 | -$57,002 |
| % Margin | -111.8% | -105.7% | -127.7% | -177.1% |
| EPS | -0.59 | -0.63 | -0.39 | -0.31 |
| % Growth | 6.3% | -61.5% | -25.8% | – |
| EPS Diluted | -0.59 | -0.63 | -0.39 | -0.31 |
| Weighted Avg Shares Out | 183,992 | 137,157 | 181,163 | 181,163 |
| Weighted Avg Shares Out Dil | 183,992 | 137,157 | 181,163 | 181,163 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8,049 | $225 | $230 | $5,480 |
| Interest Expense | $0 | $1,324 | $18,338 | $0 |
| Depreciation & Amortization | $8,049 | $225 | $3,053 | $3,157 |
| EBITDA | -$175,761 | -$85,998 | -$31,533 | -$47,800 |
| % Margin | -180% | -105.4% | -56.4% | -148.5% |